Hydrocolloid Dressing Market Size Worth $4,725.9 Mn by 2031 - Research Dive

Download Sample   Reports Overview

The Global Hydrocolloid Dressing Market Size is predicted to be valued at $4,725.9 million by 2031, surging from $2,349.1 million in 2021, at a CAGR of 7.5%.

Impact Analysis of COVID-19 on the Hydrocolloid Dressing Market

The impact of COVID-19 on the globe has been unpredictable and the pandemic has caused a negative demand almost in all markets. The COVID-19 pandemic had a negative effect on the hydrocolloid dressing market due to the cancellation or postponement of elective surgeries. The pandemic has posed a significant threat to healthcare systems worldwide. Patients with various diseases who were in desperate need of care suffered collateral damage owing to limited access to medical services. Admissions to hospitals and emergency departments for acute and life-threatening disorders such as myocardial infarction, stroke, or hyperglycemic crisis were down. Diagnosis and treatment patients are at risk of delayed diagnosis and treatment, which had a negative influence on their long-term survival. Also, millions of disabled patients, including those who survived a severe course of COVID-19 infection.  The management of patients with chronic wounds was also constrained owing to the COVID-19 pandemic and the ensuing limitations, such as self-quarantine or public lockdown. Individuals with chronic wounds are more likely to have a severe course after infection with COVID-19 due to their older age and various comorbidities. Also, nonhealing wounds that go untreated and unmanaged because wound care solutions are not readily available can result in health problems such as infection, sepsis, the need for loss of limbs, and even death.

Global Hydrocolloid Dressing Market Analysis

Hydrocolloid dressings are made of gelatin, pectin, and carboxymethyl-cellulose. They act as a protection against foreign pathogens and provide a moist environment that promotes wound healing. In comparison to wounds treated with 1% silver sulfadiazine, wounds treated with hydrocolloid occlusive dressings healed more quickly, with less pain, and required fewer dressing changes. The price of care was consequently decreased. Hydrocolloid dressings have been proven to be effective in treating small-area partial-thickness burns, and they are especially useful in the latter phases of minor burns' natural healing. Hydrocolloid dressings are most commonly used to treat ulcerative disorders such as pressure sores and lower extremity ulcers, where they have been shown to be more effective than gauze dressings in terms of ulcer healing, pain associated with dressing changes, absorption capacity, side effects, and cost. Also, they help with the management of numerous wound infections, such as those caused by donor sites, pressure sores, superficial trauma, partial thickness burns, and pediatric post-operative wounds. The main benefit of using hydrocolloid dressings to burn and donor sites is the decrease in wound discomfort. All such factors are likely to drive global hydrocolloid dressings market size in the forecast years.

The use of hydrocolloid dressings for treating diabetic foot ulcers has some limitations. Many wound care specialists believe they may increase the risk of infection as they hold onto germs and purulent wound exudate, produce a hypoxic wound environment, and result in less frequent wound monitoring. Hydrocolloid dressings are not recommended for infected wounds because of these issues. All these factors are projected to hinder the global hydrocolloid market share growth.

The hydrocolloid dressing has been used for advanced wound care management. The functionality of hydrocolloid technology has expanded in recent years due to the addition of specialized components with specific activity, such as antimicrobial compounds or infection prevention and control. Active substances utilized in many other types of solution-based products, can be added to the hydrocolloid adhesive patch and infused into the skin over time. The hydrocolloid can only be used once, which is its benefit. It lasts longer because active components are constantly functioning on the skin, avoiding the need for multiple topical applications. These characteristics have broadened the usage of hydrocolloids across a broader spectrum into other fields, such as skin care, to improve look, particularly in the facial area. The addition of salicylic acid to hydrocolloids for use on acne or other blemishes, and retinol or other active chemicals used in popular topical applications to treat fine lines and wrinkles.

Global Hydrocolloid Dressing Market Segmentation

The hydrocolloid dressing market trends is segmented on the basis of application, end user, and region.

Application:

The application segment is further classified into acute wounds, chronic wounds, and pressure wounds. Among these, the chronic wounds segment accounted for a dominant market share in 2021. The rise in the incidence of diabetes and ulcers in diabetic feet is a primary factor driving segment growth. The hydrocolloid dressing also serves as a protective covering for acute wounds because of the impermeable characteristic of hydrocolloids. This makes it possible to wash and aids in limiting the spread of pathogenic bacteria.

End User:

The end user segment is further divided into hospitals and clinics, home care settings, and diagnostic clinics. Among these, the hospitals and clinics segment accounted for a dominant market share in 2021. The high representation of this category may be attributed to factors such as the increase in the prevalence of surgical and chronic wounds and the rise in the incidence of burn injuries. The increase in the prevalence of wound ulcers and surgical wounds has resulted in an increase in the demand for hydrocolloid dressing for wound management and a reduction in hospital stay time.

Region:

The hydrocolloid dressing market growth in the North America region is projected to show the fastest growth during the forecast period. This is mostly due to reasons such as an increase in consumer knowledge, the presence of innovative items, and people's acceptance of new products. Also, the rise in the frequency of chronic wounds, combined with the demand for home healthcare, contributes to the growth of the market in this region.

Key Players in Global Hydrocolloid Dressing Market

Some of the leading hydrocolloid dressing market players are

• Smith Nephew
• 3M
• Coloplast Corp
• Convatec Inc
• Cardinal Health
• Molnlycke Inc.
• INTEGRA
• Abbott Ltd.
• Medtronic
• Cardinal Health.